For the Inventor, By the Inventor

Enter assignee name

Newark, CA, United States of America

Dna Twopointo Inc.

USPTO Granted Patents = 33

EPO Patents = 3

Trademarks = 12

Forward Citations = 183

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Jeremy S Minshull (29 out of 123 patents)

Maggie Lee (14 out of 18 patents)

Sridhar Govindarajan (11 out of 36 patents)

4. Jon Edward Ness (9 out of 42 patents)

5. Claes Gustafsson (8 out of 44 patents)

6. Mark D Welch (7 out of 40 patents)

7. Elias Theodorou (5 out of 5 patents)

8. Sridhar Govindrajan (3 out of 10 patents)

9. Kate Caves (3 out of 9 patents)

10. Varsha Sitaraman (2 out of 2 patents)

11. Ferenc Boldog (2 out of 2 patents)

12. Mark Cobbold (1 out of 15 patents)

13. Wenhua Lu (1 out of 9 patents)

14. Richard A Gross (1 out of 36 patents)

15. Alan Marco Villalobos (1 out of 1 patent)

33 patents: Sort by Forward Citations

1. 12419913 - Modification of CAR-T cells (2025-09-23),

2. 12404504 - Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis (2025-09-02),

3. 12351813 - Tetracycline-inducible expression system (2025-07-08),

4. 12351800 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2025-07-08),

5. 12122995 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-10-22),

6. 12054702 - DNA vectors, transposons and transposases for eukaryotic genome modification (2024-08-06),

7. 11845936 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2023-12-19),

8. 11713468 - DNA vectors and elements for sustained gene expression in eukaryotic cells (2023-08-01),

9. 11566262 - Tetracycline-inducible expression systems (2023-01-31),

10. 11401521 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2022-08-02),

11. 11396662 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2022-07-26),

12. 11162102 - Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products (2021-11-02),

13. 11060109 - Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois (2021-07-13),

14. 11060098 - Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias (2021-07-13),

15. 11060086 - Transposition of nucleic acids into eukaryotic genomes with a transposase from heliothis (2021-07-13),

DNA TWOPOINTO INC. is a leading technology company specializing in biotech solutions. With a focus on DNA sequencing and analysis, we provide innovative genetic tools and services that empower researchers and scientists in unlocking the mysteries of life. Our cutting-edge technology, combined with a team of experts, allows us to offer reliable and accurate solutions for a wide range of industries including healthcare, agriculture, and forensic science.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

33 Patents

#21 in Newark, CA

#2,379 in California

#9,940 in US

#19,530 in the World

Newark, CA, United States of America

Dna Twopointo Inc.

Forward Citations = 183

17 inventors:

Jeremy S Minshull (29 out of 123 patents)

Maggie Lee (14 out of 18 patents)

Sridhar Govindarajan (11 out of 36 patents)

4. Jon Edward Ness (9 out of 42 patents)

5. Claes Gustafsson (8 out of 44 patents)

Please report any incorrect information to support@idiyas.com

Loading…